107 related articles for article (PubMed ID: 8527899)
1. Fibroblast subpopulations as accelerators of tumor progression: the role of migration stimulating factor.
Schor SL
EXS; 1995; 74():273-96. PubMed ID: 8527899
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
EXS; 1991; 59():127-46. PubMed ID: 1833226
[TBL] [Abstract][Full Text] [Related]
3. Subpopulations of fetal-like gingival fibroblasts: characterisation and potential significance for wound healing and the progression of periodontal disease.
Schor SL; Ellis I; Irwin CR; Banyard J; Seneviratne K; Dolman C; Gilbert AD; Chisholm DM
Oral Dis; 1996 Jun; 2(2):155-66. PubMed ID: 8957929
[TBL] [Abstract][Full Text] [Related]
4. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing.
Irwin CR; Picardo M; Ellis I; Sloan P; Grey A; McGurk M; Schor SL
J Cell Sci; 1994 May; 107 ( Pt 5)():1333-46. PubMed ID: 7929639
[TBL] [Abstract][Full Text] [Related]
5. Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease.
Schor SL; Schor AM; Howell A; Crowther D
Exp Cell Biol; 1987; 55(1):11-7. PubMed ID: 3569635
[TBL] [Abstract][Full Text] [Related]
6. Foetal-to-adult transitions in fibroblast phenotype: their possible relevance to the pathogenesis of cancer.
Schor SL; Schor AM
J Cell Sci Suppl; 1987; 8():165-80. PubMed ID: 3332659
[TBL] [Abstract][Full Text] [Related]
7. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.
Schor SL; Schor AM; Grey AM; Chen J; Rushton G; Grant ME; Ellis I
In Vitro Cell Dev Biol; 1989 Aug; 25(8):737-46. PubMed ID: 2768134
[TBL] [Abstract][Full Text] [Related]
9. Detection of migration stimulating activity in wound fluid.
Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
[TBL] [Abstract][Full Text] [Related]
10. Fetal-like fibroblasts: their production of migration-stimulating factor and role in tumor progression.
Schor SL; Grey AM; Ellis I; Schor AM; Howell A; Sloan P; Murphy R
Cancer Treat Res; 1994; 71():277-98. PubMed ID: 7946952
[No Abstract] [Full Text] [Related]
11. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
[TBL] [Abstract][Full Text] [Related]
12. Characterization of migration-stimulating factor (MSF): evidence for its role in cancer pathogenesis.
Schor SL; Schor AM
Cancer Invest; 1990; 8(6):665-7. PubMed ID: 2292062
[No Abstract] [Full Text] [Related]
13. Involvement of partial EMT in cancer progression.
Saitoh M
J Biochem; 2018 Oct; 164(4):257-264. PubMed ID: 29726955
[TBL] [Abstract][Full Text] [Related]
14. [Epithelial-mesenchymal transition in cancer progression].
Gos M; Miłoszewska J; Przybyszewska M
Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
[TBL] [Abstract][Full Text] [Related]
15. Fetal-adult phenotype transition, in terms of the serum dependency and growth factor requirements, of human skin fibroblast migration.
Kondo H; Yonezawa Y
Exp Cell Res; 1995 Oct; 220(2):501-4. PubMed ID: 7556460
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression?
Kunz-Schughart LA; Knuechel R
Histol Histopathol; 2002 Apr; 17(2):599-621. PubMed ID: 11962761
[TBL] [Abstract][Full Text] [Related]
17. Tangled fibroblasts in tumor-stroma interactions.
Liu M; Xu J; Deng H
Int J Cancer; 2011 Oct; 129(8):1795-805. PubMed ID: 21469145
[TBL] [Abstract][Full Text] [Related]
18. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics.
Schor SL; Schor AM; Rushton G
J Cell Sci; 1988 Jul; 90 ( Pt 3)():401-7. PubMed ID: 3253290
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.
Sistigu A; Di Modugno F; Manic G; Nisticò P
Cytokine Growth Factor Rev; 2017 Aug; 36():67-77. PubMed ID: 28595838
[TBL] [Abstract][Full Text] [Related]
20. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
